EverSource Wealth Advisors, LLC

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 1710537 BIRMINGHAM, AL

Position in ZNTL

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$3,975

+$1,756 QoQ

Shares Held

1,699

+3.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

EverSource Wealth Advisors, LLC holds $14,908,537 across 266 Biotechnology names. ZNTL ranks #141 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRSP	CRISPR Therapeutics AG	89,683	$4,266,217
2	REGN	Regeneron Pharmaceuticals, Inc.	1,880	$1,452,556
3	INCY	Incyte Corp	13,070	$1,230,145
4	VRTX	Vertex Pharmaceuticals Inc / Ma	1,507	$672,929
5	RPRX	Royalty Pharma plc	12,629	$605,808
6	TNGX	Tango Therapeutics, Inc.	26,026	$544,460
7	EXEL	Exelixis, Inc.	11,015	$472,428
8	BMRN	Biomarin Pharmaceutical Inc	6,845	$386,665

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,975	1,699	+3.3%	Shares	Sole	2026-05-18
2025-12-31	$2,219	1,644	-36.6%	Shares	Sole	2026-02-06
2025-09-30	$3,915	2,593	+10.3%	Shares	Sole	2025-11-10
2025-06-30	$2,724	2,350	-5.1%	Shares	Sole	2025-08-13
2025-03-31	$3,936	2,477	-26.2%	Shares	Sole	2025-05-13
2024-12-31	$10,167	3,356	+2.7%	Shares	Sole	2025-02-10
2024-09-30	$12,029	3,269	+16.9%	Shares	Sole	2024-11-08
2024-06-30	$11,438	2,797	+73.7%	Shares	Sole	2024-08-13
2024-03-31	$25,373	1,610	+54.1%	Shares	Sole	2024-06-11
2023-12-31	$15,831	1,045	+641.1%	Shares	Sole	2024-02-09
2023-09-30	$2,828	141	0.0%	Shares	Sole	2023-11-03
2023-06-30	$3,977	141	—	Shares	Sole	2023-08-04
No filing history on record for this holder in this stock.